Journal
Frontiers in Oncology
Publication Date
1-1-2023
Volume
13
First Page
1118268
Document Type
Open Access Publication
DOI
10.3389/fonc.2023.1118268
Rights and Permissions
Eloranta K, Pihlajoki M, Liljeström E, Nousiainen R, Soini T, Lohi J, Cairo S, Wilson DB, Parkkila S and Heikinheimo M (2023) SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration. Front. Oncol. 13:1118268. doi: 10.3389/fonc.2023.1118268 © 2023 Eloranta, Pihlajoki, Liljeström, Nousiainen, Soini, Lohi, Cairo, Wilson, Parkkila and Heikinheimo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Eloranta, Katja; Pihlajoki, Marjut; Liljeström, Emmi; Nousiainen, Ruth; Soini, Tea; Lohi, Jouko; Cairo, Stefano; Wilson, David B; Parkkila, Seppo; and Heikinheimo, Markku, "SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration." Frontiers in Oncology. 13, 1118268 (2023).
https://digitalcommons.wustl.edu/oa_4/2566
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
